|
|
Expression and Function of S100A8/A9 (Calprotectin) in Human Typhoid Fever and the Murine Salmonella Model
|
|
|
|
|
نویسنده
|
de jong h.k. ,achouiti a. ,koh g.c.k.w. ,parry c.m. ,baker s. ,faiz m.a. ,van dissel j.t. ,vollaard a.m. ,van leeuwen e.m.m. ,roelofs j.j.t.h. ,de vos a.f. ,roth j. ,van der poll t. ,vogl t. ,wiersinga w.j.
|
منبع
|
plos neglected tropical diseases - 2015 - دوره : 9 - شماره : 4
|
چکیده
|
Typhoid fever,caused by the gram-negative bacterium salmonella enterica serovar typhi,is a major cause of community-acquired bacteremia and death worldwide. s100a8 (mrp8) and s100a9 (mrp14) form bioactive antimicrobial heterodimers (calprotectin) that can activate toll-like receptor 4,promoting lethal,endotoxin-induced shock and multi-organ failure. we aimed to characterize the expression and function of s100a8/a9 in patients with typhoid fever and in a murine invasive salmonella model. s100a8/a9 protein levels were determined in acute phase plasma or feces from 28 bangladeshi patients,and convalescent phase plasma from 60 indonesian patients with blood culture or pcr-confirmed typhoid fever,and compared to 98 healthy control subjects. to functionally characterize the role of s100a8/a9,we challenged wildtype (wt) and s100a9-/- mice with s. typhimurium and determined bacterial loads and inflammation 2- and 5- days post infection. we further assessed the antimicrobial function of recombinant s100a8/a9 on s. typhimurium and s. typhi replication in vitro. typhoid fever patients demonstrated a marked increase of s100a8/a9 in acute phase plasma and feces and this increases correlated with duration of fever prior to admission. s100a8/a9 directly inhibited the growth of s. typhimurium and s. typhi in vitro in a dose and time dependent fashion. wt mice inoculated with s. typhimurium showed increased levels of s100a8/a9 in both the liver and the systemic compartment but s100a9-/- mice were indistinguishable from wt mice with respect to bacterial growth,survival,and inflammatory responses,as determined by cytokine release,histopathology and organ injury. s100a8/a9 is markedly elevated in human typhoid,correlates with duration of fever prior to admission and directly inhibits the growth of s. typhimurium and s. typhi in vitro. despite elevated levels in the murine invasive salmonella model,s100a8/a9 does not contribute to an effective host response against s. typhimurium in mice. © 2015 de jong et al.
|
|
|
آدرس
|
department of internal medicine,division of infectious diseases,center for infection and immunity amsterdam (cinima),center for experimental molecular medicine (cemm),academic medical center,university of amsterdam,amsterdam, Netherlands, department of internal medicine,division of infectious diseases,center for infection and immunity amsterdam (cinima),center for experimental molecular medicine (cemm),academic medical center,university of amsterdam,amsterdam, Netherlands, department of internal medicine,division of infectious diseases,center for infection and immunity amsterdam (cinima),center for experimental molecular medicine (cemm),academic medical center,university of amsterdam,amsterdam,netherlands,department of medicine,addenbrooke’s hospital,university of cambridge,cambridge, United Kingdom, mahidol-oxford tropical medicine research unit (moru),mahidol university,bangkok,thailand,center for tropical medicine,nuffield department of clinical medicine,churchill hospital,oxford,united kingdom,clinical sciences,liverpool school of tropical medicine,liverpool, United Kingdom, center for tropical medicine,nuffield department of clinical medicine,churchill hospital,oxford,united kingdom,wellcome trust major overseas programme,oxford university clinical research unit (oucru),ho chi minh city, Viet Nam, mahidol-oxford tropical medicine research unit (moru),mahidol university,bangkok,thailand,chittagong medical college hospital,chittagong, Bangladesh, department of infectious diseases,leiden university medical center,leiden, Netherlands, department of infectious diseases,leiden university medical center,leiden, Netherlands, department of experimental immunology,academic medical center,amsterdam,university of amsterdam,amsterdam, Netherlands, department of pathology,academic medical center,amsterdam,university of amsterdam,amsterdam, Netherlands, department of internal medicine,division of infectious diseases,center for infection and immunity amsterdam (cinima),center for experimental molecular medicine (cemm),academic medical center,university of amsterdam,amsterdam, Netherlands, institute of immunology,university of muenster,muenster, Germany, department of internal medicine,division of infectious diseases,center for infection and immunity amsterdam (cinima),center for experimental molecular medicine (cemm),academic medical center,university of amsterdam,amsterdam, Netherlands, institute of immunology,university of muenster,muenster, Germany, department of internal medicine,division of infectious diseases,center for infection and immunity amsterdam (cinima),center for experimental molecular medicine (cemm),academic medical center,university of amsterdam,amsterdam, Netherlands
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|